ArticleRMD open2022

Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France.

Maxime Dougados et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.